These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 27793046)

  • 1. Transcriptional upregulation of c-MET is associated with invasion and tumor budding in colorectal cancer.
    Bradley CA; Dunne PD; Bingham V; McQuaid S; Khawaja H; Craig S; James J; Moore WL; McArt DG; Lawler M; Dasgupta S; Johnston PG; Van Schaeybroeck S
    Oncotarget; 2016 Nov; 7(48):78932-78945. PubMed ID: 27793046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of HGF/c-Met in the treatment of colorectal cancer with liver metastasis.
    Yao JF; Li XJ; Yan LK; He S; Zheng JB; Wang XR; Zhou PH; Zhang L; Wei GB; Sun XJ
    J Biochem Mol Toxicol; 2019 Jun; 33(6):e22316. PubMed ID: 30897285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CREB5 promotes invasiveness and metastasis in colorectal cancer by directly activating MET.
    Wang S; Qiu J; Liu L; Su C; Qi L; Huang C; Chen X; Zhang Y; Ye Y; Ding Y; Liang L; Liao W
    J Exp Clin Cancer Res; 2020 Aug; 39(1):168. PubMed ID: 32843066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FOXC2 promotes colorectal cancer metastasis by directly targeting MET.
    Cui YM; Jiao HL; Ye YP; Chen CM; Wang JX; Tang N; Li TT; Lin J; Qi L; Wu P; Wang SY; He MR; Liang L; Bian XW; Liao WT; Ding YQ
    Oncogene; 2015 Aug; 34(33):4379-90. PubMed ID: 25381815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of aggressive hepatectomy for colorectal liver metastasis, evaluated from the HGF/c-Met pathway.
    Matsui S; Osada S; Tomita H; Komori S; Mori R; Sanada Y; Takahashi T; Yamaguchi K; Yoshida K
    Int J Oncol; 2010 Aug; 37(2):289-97. PubMed ID: 20596656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Karyopherin β1 deletion suppresses tumor growth and metastasis in colorectal cancer (CRC) by reducing MET expression.
    Zhang Y; Li KF
    Biomed Pharmacother; 2019 Dec; 120():109127. PubMed ID: 31629952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogenic long intervening noncoding RNA Linc00284 promotes c-Met expression by sponging miR-27a in colorectal cancer.
    You J; Li J; Ke C; Xiao Y; Lu C; Huang F; Mi Y; Xia R; Li Q
    Oncogene; 2021 Jun; 40(24):4151-4166. PubMed ID: 34050266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of HGF and Met in human tissues of colorectal cancers: biological and clinical implications for synchronous liver metastasis.
    Sun YL; Liu WD; Ma GY; Gao DW; Jiang YZ; Liu Q; Du JJ
    Int J Med Sci; 2013; 10(5):548-59. PubMed ID: 23532910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic instability causes HGF gene activation in colon cancer cells, promoting their resistance to necroptosis.
    Seneviratne D; Ma J; Tan X; Kwon YK; Muhammad E; Melhem M; DeFrances MC; Zarnegar R
    Gastroenterology; 2015 Jan; 148(1):181-191.e17. PubMed ID: 25244939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulinlike growth factor-I-mediated migration and invasion of human colon carcinoma cells requires activation of c-Met and urokinase plasminogen activator receptor.
    Bauer TW; Fan F; Liu W; Johnson M; Parikh NU; Parry GC; Callahan J; Mazar AP; Gallick GE; Ellis LM
    Ann Surg; 2005 May; 241(5):748-56; discussion 756-8. PubMed ID: 15849510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long Noncoding RNA GAPLINC Promotes Cells Migration and Invasion in Colorectal Cancer Cell by Regulating miR-34a/c-MET Signal Pathway.
    Luo Y; Ouyang J; Zhou D; Zhong S; Wen M; Ou W; Yu H; Jia L; Huang Y
    Dig Dis Sci; 2018 Apr; 63(4):890-899. PubMed ID: 29427222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SOX13 promotes colorectal cancer metastasis by transactivating SNAI2 and c-MET.
    Du F; Li X; Feng W; Qiao C; Chen J; Jiang M; Qiu Z; Qian M; Tian D; Nie Y; Fan D; Wu K; Xia L
    Oncogene; 2020 Apr; 39(17):3522-3540. PubMed ID: 32111984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and characterization of ANO9 in stage II and III colorectal carcinoma.
    Li C; Cai S; Wang X; Jiang Z
    Oncotarget; 2015 Oct; 6(30):29324-34. PubMed ID: 26317553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bromodomain and Extraterminal (BET) protein inhibition suppresses tumor progression and inhibits HGF-MET signaling through targeting cancer-associated fibroblasts in colorectal cancer.
    Wen D; Wang Y; Zhu Z; Huang Z; Cui L; Wu T; Liu CY
    Biochim Biophys Acta Mol Basis Dis; 2020 Dec; 1866(12):165923. PubMed ID: 32800944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of Src by c-Met overexpression mediates metastatic properties of colorectal carcinoma cells.
    Herynk MH; Zhang J; Parikh NU; Gallick GE
    J Exp Ther Oncol; 2007; 6(3):205-17. PubMed ID: 17552361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA CASC11 interacts with hnRNP-K and activates the WNT/β-catenin pathway to promote growth and metastasis in colorectal cancer.
    Zhang Z; Zhou C; Chang Y; Zhang Z; Hu Y; Zhang F; Lu Y; Zheng L; Zhang W; Li X; Li X
    Cancer Lett; 2016 Jun; 376(1):62-73. PubMed ID: 27012187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spatiotemporal regulation of the hepatocyte growth factor receptor MET activity by sorting nexins 1/2 in HCT116 colorectal cancer cells.
    Garcia Delgado L; Derome A; Longpré S; Giroux-Dansereau M; Basbous G; Lavoie C; Saucier C; Denault JB
    Biosci Rep; 2024 Jun; 44(6):. PubMed ID: 38836326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. microRNA -140-5p inhibits colorectal cancer invasion and metastasis by targeting ADAMTS5 and IGFBP5.
    Yu L; Lu Y; Han X; Zhao W; Li J; Mao J; Wang B; Shen J; Fan S; Wang L; Wang M; Li L; Tang J; Song B
    Stem Cell Res Ther; 2016 Dec; 7(1):180. PubMed ID: 27906093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-expression of hepatocyte growth factor and c-Met predicts peritoneal dissemination established by autocrine hepatocyte growth factor/c-Met signaling in gastric cancer.
    Toiyama Y; Yasuda H; Saigusa S; Matushita K; Fujikawa H; Tanaka K; Mohri Y; Inoue Y; Goel A; Kusunoki M
    Int J Cancer; 2012 Jun; 130(12):2912-21. PubMed ID: 21796631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocyte growth factor/MET in cancer progression and biomarker discovery.
    Matsumoto K; Umitsu M; De Silva DM; Roy A; Bottaro DP
    Cancer Sci; 2017 Mar; 108(3):296-307. PubMed ID: 28064454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.